1 April 2024 false No description of principal activity Taxfiler 2024.6 11911410business:PrivateLimitedCompanyLtd2024-04-012025-03-31 119114102024-03-31 119114102024-04-012025-03-31 11911410business:AuditExemptWithAccountantsReport2024-04-012025-03-31 11911410business:FilletedAccounts2024-04-012025-03-31 119114102025-03-31 11911410business:Director12024-04-012025-03-31 11911410business:Director22024-04-012025-03-31 11911410business:RegisteredOffice2024-04-012025-03-31 119114102024-03-31 11911410core:WithinOneYear2025-03-31 11911410core:WithinOneYear2024-03-31 11911410core:AfterOneYear2025-03-31 11911410core:AfterOneYear2024-03-31 11911410core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 11911410core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 11911410core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 11911410core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 11911410core:PreviouslyStatedAmount2025-03-31 11911410core:PreviouslyStatedAmount2024-03-31 11911410business:SmallEntities2024-04-012025-03-31 11911410countries:EnglandWales2024-04-012025-03-31 11911410core:LandBuildings2024-03-31 11911410core:LandBuildings2025-03-31 119114102023-04-012024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 11911410 (England and Wales)
KKAN PHARMA LTD Unaudited accounts for the year ended 31 March 2025
KKAN PHARMA LTD Unaudited accounts Contents
Page
- 2 -
KKAN PHARMA LTD Company Information for the year ended 31 March 2025
Directors
MANISHKUMAR SHAH Dhipal Maulik DESAI
Company Number
11911410 (England and Wales)
Registered Office
17 WESTBURY CLOSE HOUGHTON REGIS DUNSTABLE LU5 5BL ENGLAND
Accountants
AGM Business Solutions 98 Exeter Road Harrow HA2 9PL
- 3 -
KKAN PHARMA LTD Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
630,100 
630,100 
Current assets
Inventories
560,330 
446,565 
Debtors
- 
41,390 
Cash at bank and in hand
294,452 
252,119 
854,782 
740,074 
Creditors: amounts falling due within one year
(365,719)
(446,079)
Net current assets
489,063 
293,995 
Total assets less current liabilities
1,119,163 
924,095 
Creditors: amounts falling due after more than one year
(655,667)
(705,315)
Net assets
463,496 
218,780 
Capital and reserves
Called up share capital
1,000 
1,000 
Profit and loss account
462,496 
217,780 
Shareholders' funds
463,496 
218,780 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 19 May 2025 and were signed on its behalf by
MANISHKUMAR SHAH Director Company Registration No. 11911410
- 4 -
KKAN PHARMA LTD Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
KKAN PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 11911410. The registered office is 17 WESTBURY CLOSE, HOUGHTON REGIS, DUNSTABLE, LU5 5BL, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Tangible fixed assets
Land & buildings 
£ 
Cost or valuation
At cost 
At 1 April 2024
630,100 
At 31 March 2025
630,100 
Depreciation
At 31 March 2025
- 
Net book value
At 31 March 2025
630,100 
At 31 March 2024
630,100 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
- 
21,540 
Trade debtors
- 
19,850 
- 
41,390 
- 5 -
KKAN PHARMA LTD Notes to the Accounts for the year ended 31 March 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
VAT
53,676 
- 
Trade creditors
210,472 
188,118 
Taxes and social security
81,571 
27,862 
Other creditors
- 
210,099 
Accruals
20,000 
20,000 
365,719 
446,079 
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Bank loans
460,337 
470,315 
Loans from directors
195,330 
235,000 
655,667 
705,315 
8
Average number of employees
During the year the average number of employees was 6 (2024: 3).
- 6 -